OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Summary by AI BETAClose X

OKYO Pharma Limited announced its participation in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026, where it will present investigational therapies for neuropathic corneal pain and anterior segment eye diseases. The company also revealed plans to initiate a global Phase 3 pivotal clinical trial in the second half of the year, enrolling approximately 111 patients to evaluate a single-dose regimen of urcosimod for neuropathic corneal pain.

Disclaimer*

UK 100

Latest directors dealings